This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, Y. Articles by Gubler, M.-C. Search for Related Content PubMed PubMed Citation Articles by Yang, Y. Articles by Gubler, M.-C.

(American Journal of Pathology. 1999;154:181-192.)
© 1999 American Society for Investigative Pathology

Regular Articles

WT1 and PAX-2 Podocyte Expression in Denys-Drash Syndrome and Isolated Diffuse Mesangial Sclerosis

Youxin Yang* , Cécile Jeanpierre , Gregory R. Dressler , Mireille Lacoste* , Patrick Niaudet* and Marie-Claire Gubler*

From INSERM U.423* and INSERM U383, Hôpital Necker-Enfants Malades, Université René Descartes, Paris, France and the Department of Pathology, Howard Hughes Medical Institute, Ann Arbor, Michigan

Denys-Drash syndrome is a rare disorder of urogenital development characterized by the association of early onset glomerulopathy caused by diffuse mesangial sclerosis, gonadal dysgenesis leading to pseudohermaphroditism in males, and a high risk of developing Wilms' tumor. The syndrome is caused by dominant negative point mutations in the WT1 gene that encodes a tumor suppressor transcription factor normally expressed in podocytes. Mutations usually affect the zinc fingers of the WT1 protein. The basic defect is unknown in most cases of isolated diffuse mesangial sclerosis, a disease characterized by the same glomerular changes as in Denys-Drash syndrome but possibly transmitted as an autosomal recessive trait. Here we show that the distribution of WT1 is abnormal in most patients with Denys-Drash syndrome : WT1 nuclear staining of podocytes is decreased or absent. This finding is consistent with the decreased DNA binding capacity of the mutated protein. One target gene of WT1 is PAX2, the expression of which is down-regulated in podocytes during early stages of nephrogenesis. We demonstrate that WT1 mislocalization is associated with abnormal podocyte expression of PAX2 protein and RNA. We suggest that persistent expression of PAX2 is likely to result from the loss of WT1 dependent transcriptional repression and may participate in the pathological mechanisms leading to glomerular dysfunction. Abnormal distribution of WT1 and PAX2 was also observed in isolated diffuse mesangial sclerosis suggesting that a defect in WT1 could also be operative in isolated diffuse mesangial sclerosis. Primary involvement of PAX2 is an alternative hypothesis because persistent expression of PAX2 in transgenic mice is associated with the occurrence of early and severe glomerulopathy.

This article has been cited by other articles:

				A. A. Morrison, R. L. Viney, M. A. Saleem, and M. R. Ladomery New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes Am J Physiol Renal Physiol, July 1, 2008; 295(1): F12 - F17. [Abstract] [Full Text] [PDF]

				A. M. Waters, M. Y.J. Wu, T. Onay, J. Scutaru, J. Liu, C. G. Lobe, S. E. Quaggin, and T. D. Piscione Ectopic Notch Activation in Developing Podocytes Causes Glomerulosclerosis J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1139 - 1157. [Full Text] [PDF]

				R. Gbadegesin, B. G. Hinkes, B. E. Hoskins, C. N. Vlangos, S. F. Heeringa, J. Liu, C. Loirat, F. Ozaltin, S. Hashmi, F. Ulmer, et al. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS) Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1291 - 1297. [Abstract] [Full Text] [PDF]

				H Rosas-Vargas, N Bahi-Buisson, C Philippe, J Nectoux, B Girard, M A N'Guyen Morel, C Gitiaux, L Lazaro, S Odent, P Jonveaux, et al. Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy J. Med. Genet., March 1, 2008; 45(3): 172 - 178. [Abstract] [Full Text] [PDF]

				L. Barisoni, H. W. Schnaper, and J. B. Kopp A Proposed Taxonomy for the Podocytopathies: A Reassessment of the Primary Nephrotic Diseases Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 529 - 542. [Abstract] [Full Text] [PDF]

				G. Liu, L. C. Clement, Y. S. Kanwar, C. Avila-Casado, and S. S. Chugh ZHX Proteins Regulate Podocyte Gene Expression during the Development of Nephrotic Syndrome J. Biol. Chem., December 22, 2006; 281(51): 39681 - 39692. [Abstract] [Full Text] [PDF]

				J. Bariety, C. Mandet, G. S. Hill, and P. Bruneval Parietal Podocytes in Normal Human Glomeruli J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2770 - 2780. [Abstract] [Full Text] [PDF]

				J.-K. Guo, A. Schedl, and D. S. Krause Bone Marrow Transplantation Can Attenuate the Progression of Mesangial Sclerosis Stem Cells, February 1, 2006; 24(2): 406 - 415. [Abstract] [Full Text] [PDF]

				J. S. Jaggi, S. V. Seshan, M. R. McDevitt, K. LaPerle, G. Sgouros, and D. A. Scheinberg Renal Tubulointerstitial Changes after Internal Irradiation with {alpha}-Particle-Emitting Actinium Daughters J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2677 - 2689. [Abstract] [Full Text] [PDF]

				N. Sabherwal, K. U. Schneider, R. J. Blaschke, A. Marchini, and G. Rappold Impairment of SHOX nuclear localization as a cause for Leri-Weill syndrome J. Cell Sci., June 15, 2004; 117(14): 3041 - 3048. [Abstract] [Full Text] [PDF]

				H. Schmid, A. Henger, C. D. Cohen, K. Frach, H.-J. Grone, D. Schlondorff, and M. Kretzler Gene Expression Profiles of Podocyte-Associated Molecules as Diagnostic Markers in Acquired Proteinuric Diseases J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2958 - 2966. [Abstract] [Full Text] [PDF]

				C. E. Patek, S. Fleming, C. G. Miles, C. O. Bellamy, M. Ladomery, L. Spraggon, J. Mullins, N. D. Hastie, and M. L. Hooper Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis Hum. Mol. Genet., September 15, 2003; 12(18): 2379 - 2394. [Abstract] [Full Text] [PDF]

				J.-K. Guo, A. L. Menke, M.-C. Gubler, A. R. Clarke, D. Harrison, A. Hammes, N. D. Hastie, and A. Schedl WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis Hum. Mol. Genet., March 1, 2002; 11(6): 651 - 659. [Abstract] [Full Text] [PDF]

				V. Chauvet, F. Qian, N. Boute, Y. Cai, B. Phakdeekitacharoen, L. F. Onuchic, T. Attie-Bitach, L. Guicharnaud, O. Devuyst, G. G. Germino, et al. Expression of PKD1 and PKD2 Transcripts and Proteins in Human Embryo and during Normal Kidney Development Am. J. Pathol., March 1, 2002; 160(3): 973 - 983. [Abstract] [Full Text] [PDF]

				S. Roselli, O. Gribouval, N. Boute, M. Sich, F. Benessy, T. Attie, M.-C. Gubler, and C. Antignac Podocin Localizes in the Kidney to the Slit Diaphragm Area Am. J. Pathol., January 1, 2002; 160(1): 131 - 139. [Abstract] [Full Text] [PDF]

				C. MROWKA and A. SCHEDL Wilms' Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 106S - 115. [Abstract] [Full Text]

				C. A. Gomez, L. M. Ptaszek, A. Villa, F. Bozzi, C. Sobacchi, E. G. Brooks, L. D. Notarangelo, E. Spanopoulou, Z. Q. Pan, P. Vezzoni, et al. Mutations in Conserved Regions of the Predicted RAG2 Kelch Repeats Block Initiation of V(D)J Recombination and Result in Primary Immunodeficiencies Mol. Cell. Biol., August 1, 2000; 20(15): 5653 - 5664. [Abstract] [Full Text]

				A. Majumdar, K. Lun, M. Brand, and I. A. Drummond Zebrafish no isthmus reveals a role for pax2.1 in tubule differentiation and patterning events in the pronephric primordia Development, May 15, 2000; 127(10): 2089 - 2098. [Abstract] [PDF]

				L. DEMMER, W. PRIMACK, V. LOIK, R. BROWN, N. THERVILLE, and K. MCELREAVEY Frasier Syndrome: A Cause of Focal Segmental Glomerulosclerosis in a46,XX Female J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2215 - 2218. [Abstract] [Full Text]

				M. M. SCHWARTZ, J. EVANS, R. BAIN, and S. M. KORBET Focal Segmental Glomerulosclerosis: Prognostic Implications of theCellular Lesion J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1900 - 1907. [Abstract] [Full Text]